Dl-alpha-tocopherol acetate

규격

52225-20-4CAS 번호

231-710-0EC 번호

[2,5,7,8-tetramethyl-2-(4,8,12-trimethyltridecyl)-3,4-dihydrochromen-6-yl] acetateIUPAC 명칭

C31H52O3화학식

472.7 g/mol분자량

DL-alpha-Tocopherol acetate; 52225-20-4; all-rac-alpha-Tocopheryl acetate; (+-)-alpha-Tocopherol acetate; WR1WPI7EW8; Alpha-tocopherol acetate, dl-; [2,5,7,8-tetramethyl-2-(4,8,12-trimethyltridecyl)-3,4-dihydrochromen-6-yl] acetate; Tocopheryl Acetate, dl-Alpha; Alpha-tocopheryl acetate, dl-; J262.912G; (2,5,7,8-tetramethyl-2-(4,8,12-trimethyltridecyl)-3,4-dihydrochromen-6-yl) acetate; Vitamin E acetate dl-; RefChem:1083891; Tocopheryl acetate,dl-alpha; d,l-alpha-Tocopherol Acetate; NSC379576; 257-757-7; 7695-91-2; Tocopheryl acetate; Vitamin E acetate; alpha-tochopheryl acetate; dl-Vitamin E acetate; E-vicotrat; DL-alpha tocopheryl acetate; Syntopherol acetate; Rovimix E 50SD; dl-a-tocopherol acetate; Vitamin E acetate dl-form; Acetic acid alpha-tocopherol; ( inverted exclamation markA)-|A-Tocopherol acetate; d,l-alpha-Tocopheryl acetate; Spondyvit; dl-.alpha.-Tocopherol acetate; Epsilan-M; E-Toplex; E-Ferol; d-Vitamin E acetate; MFCD00072042; (R)-rel-2,5,7,8-Tetramethyl-2-((4R,8R)-4,8,12-trimethyltridecyl)chroman-6-yl acetate; D-.alpha.-Tocopheryl acetate; alpha-Tocopherol acetate, all rac; a-tocopherol acetate; Vectan (TN); 2,5,7,8-Tetramethyl-2-(4,8,12-trimethyltridecyl)-3,4-dihydro-2H-chromen-6-yl acetate; SMR000857224; DL-?-Tocopherol Acetate; O-Acetyl-alpha-tocopherol; .alpha.-Tocopheryl acetate; SR-05000001545; D-.alpha.-Tocopherol acetate; (+)-alpha-Tocopheryl acetate; (+)-.alpha.-Tocopherol acetate; (+)-.alpha.-Tocopheryl acetate; Eusovit; Vectan; (R,R,R)-alpha-Tocopheryl acetate; (R,R,R)-.alpha.-Tocopheryl acetate; OptoVit E; SynAC; NSC-755840; Vitamine E Acetate; Rovimix E 50; (2R,4'R,8'R)-.alpha.-Tocopheryl acetate; d-a-tocopherol acetate; Spectrum_000257; Tocopherol Impurity 20; alpha -tocopherol acetate; alpha -tocopheryl acetate; Spectrum2_000743; Spectrum3_001339; Spectrum4_001814; Spectrum5_000547; UNII-WR1WPI7EW8; DL Acetyl-alpha-Tocopherol; D-alpha -tocopherol acetate; D-alpha -tocopheryl acetate; Tocopherol acetate (JP15); alpha-Tocopheryl acetate CRS; BSPBio_003097; KBioGR_002452; KBioSS_000737; SPECTRUM310040; MLS001333081; MLS001333082; DivK1c_000803; dl-.alpha.-Tocopheryl acetate; SPBio_000726; (+)-alpha -tocopherol acetate; (+)-alpha -tocopheryl acetate; all-rac-alfa-tocopheryl acetate; CCRIS 6054; CHEMBL247481; orb1684640; orb2901074; orb3025611; SCHEMBL1007153; Tocopheryl acetate, dl-.alpha.; SCHEMBL29350726; (+/-)-alpha-tocopherol acetate; .alpha.-tocopherol acetate, dl-; .alpha.-tocopheryl acetate, dl-; HMS502I05; HY-B1278B; KBio1_000803; KBio2_000737; KBio2_003305; KBio2_005873; KBio3_002317; DTXSID20859032; MSK1559; 2,5,7,8-Tetramethyl-2-(4,8,12-trimethyltridecyl)-3,4-dihydro-2H-chromen-6-yl acetate #; CHEBI:182695; NINDS_000803; HMS1923I05; HMS2091C13; HMS2233A03; HMS3373K10; HMS5081L18; HMS5087K04; Pharmakon1600-00310040; [2R-[2R*(4R,8R*)]]-3,4-Dihydro-2,5,7,8-tetramethyl-2-(4,8,12-trimethyltridecyl)-2H-1-benzopyran-6-ol acetate; 2H-1-Benzopyran-6-ol, 3,4-dihydro-2,5,7,8-tetramethyl-2-((4R,8R)-4,8,12-trimethyltridecyl)-, acetate, (2R)-rel-; EINECS 257-757-7; CCG-40138; HSCI1_000393; MSK169821; NSC755840; SBB012605; TN1590; [2,5,7,8-tetramethyl-2-(4,8,12-trimethyltridecyl)chroman-6-yl] acetate; AKOS015896288; MSK1559-1000M; SDCCGMLS-0066580.P001; 2,5,7,8-tetramethyl-2-(4,8,12-trimethyltridecyl)-3,4-dihydro-2H-1-benzopyran-6-yl acetate; IDI1_000803; NCGC00095255-01; NCGC00095255-02; NCGC00095255-03; NCGC00095255-05; NCGC00095255-06; (2R,4'R,8'R)-alpha-Tocopherol acetate; DA-62949; DA-78521; LS-15321; ST072191; SY057051; SBI-0051262.P003; DL-.ALPHA.-TOCOPHEROL ACETATE [MI]; TOCOPHERYL ACETATE,DL-ALPHA [VANDF]; CS-0136499; DL-ALPHA TOCOPHERYL ACETATE [WHO-DD]; NS00076549; T0252; .ALPHA.-TOCOPHEROL ACETATE, DL- [II]; .ALPHA.-TOCOPHEROL ACETATE, ALL-RACEMIC; ALL-RAC-ALPHA-TOCOPHERYL ACETATE [FCC]; DL-alpha-Tocopherol acetate; Tocopheryl acetate; E81691; SBI-0051262.0001; T35379; AB00051899_06; F851352; .ALPHA.-TOCOPHEROL ACETATE, DL-, DL-, DL-; SR-05000001545-1; SR-05000001545-4; BRD-A61850409-001-10-7; DL-alpha-Tocopherylacetate (mixture of diastereomers); Q27292783; vitamin E acetate, (2R-(2R*(4R*,8R*)))-isomer; all-rac-|A-Tocopheryl acetate; DL-|A-Tocopherol Acetate; vitamin E acetate, ((2R*(4R*,8R*))-(+-))-isomer; All-rac-alpha-tocopheryl acetate for peak identification CRS; 3FA20801-746B-4265-AD7D-988D692C04CF; (R)-rel-2,5,7,8-Tetramethyl-2-((4R,8R)-4,8,12-trimethyltridecyl)chroman-6-ylacetate; DL-_-Tocopherylacetate (mixture of diastereomers) Solution in Methanol, 1000_g/mL; (2R*(4R*,8R*))-(1)-3,4-Dihydro-2,5,7,8-tetramethyl-2-(4,8,12-trimethyltridecyl)-2H-benzopyran-6-yl acetate; 2H-1-Benzopyran-6-ol, 3,4-dihydro-2,5,7,8-tetramethyl-2-(4,8,12-trimethyltridecyl)-, acetate,(2R*(4R*,8R*))-(+-)-; All-rac-alpha-tocopheryl acetat; D-alpha tocopheryl acetat (RRR-alpha tocopheryl acetat)동의어